Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1988 • 1,698 citations

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1992 • 1,290 citations

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

1992 • 1,259 citations

B70 antigen is a second ligand for CTLA-4 and CD28

1993 • 907 citations

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

1989 • 775 citations

T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.

1990 • 745 citations

CELL ADHESION MOLECULES: Implications for a Molecular Histology

1991 • 707 citations

Role of the CD28 receptor in T-cell activation

1990 • 684 citations

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

1989 • 662 citations

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1991 • 554 citations

Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation

1993 • 517 citations

Adult and embryonic mouse neural cell adhesion molecules have different binding properties

1983 • 350 citations

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.

1991 • 334 citations

NCAM polysialic acid can regulate both cell-cell and cell-substrate interactions.

1991 • 317 citations

Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19)

1990 • 314 citations

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma

1994 • 293 citations

Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry

1990 • 256 citations

Human B Lymphocytes: Phenotype, Proliferation, and Differentiation

1992 • 255 citations

Activation of human B lymphocytes through CD40 and interleukin 4

1989 • 227 citations

Staging and kinetics of multiple myeloma.

1986 • 215 citations

NCAM: Structural diversity, function and regulation of expression

1992 • 152 citations

Identification of immature and mature myeloma cells in the bone marrow of human myelomas

1993 • 145 citations

Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells

1993 • 141 citations

CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.

1994 • 112 citations

Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells

1992 • 112 citations

In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma

1991 • 91 citations

Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.

1987 • 80 citations

Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells

1992 • 76 citations

Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.

1993 • 73 citations

Lack of IL‐1 secretion from human myeloma cells highly purified by immunomagnetic separation

1993 • 64 citations

Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases.

1993 • 62 citations

Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: A comparative study

1978 • 52 citations

Multiple myeloma: ‘early’ plasma cell phenotype identifies patients with aggressive biological and clinical characteristics

1993 • 41 citations